Carolyn Cross reduces stake in Ondine Biomedical to 23%

Investing.comThursday, September 4, 2025 at 4:18:42 PM
Carolyn Cross reduces stake in Ondine Biomedical to 23%
Carolyn Cross has reduced her stake in Ondine Biomedical to 23%. This change in ownership may impact the company's future direction and investor confidence.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Ready to build your own newsroom?

Subscribe to unlock a personalised feed, podcasts, newsletters, and notifications tailored to the topics you actually care about